Sofinnova Partners

Sofinnova Partners company information, Employees & Contact Information

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to positively impact our collective future. Founded in 1972, Sofinnova Partners is a deeply-established venture capital firm in Europe, with 50 years of experience backing over 500 companies and creating market leaders around the globe. Today, Sofinnova Partners has over €4 billion under management. For more information, please visit: www.sofinnovapartners.com

Company Details

Employees
109
Founded
-
Address
7-11, Boulevard Haussmann, Paris,ile-De-France 75009,france
Phone
+33 (0)1 76 23 41 00
Email
in****@****ers.com
Industry
Financial Services
NAICS
Finance and Insurance
Monetary Authorities-Central Bank
HQ
Paris, Ile-de-France
Looking for a particular Sofinnova Partners employee's phone or email?

Sofinnova Partners Questions

News

How Sofinnova Partners orchestrated a biotech comeback - BioXconomy

How Sofinnova Partners orchestrated a biotech comeback BioXconomy

Sofinnova Partners Exceeds Target With €165M Biotech Acceleration Fund, Europe’s Largest, With Strong Pharma Support - Business Wire

Sofinnova Partners Exceeds Target With €165M Biotech Acceleration Fund, Europe’s Largest, With Strong Pharma Support Business Wire

Sofinnova taps NVIDIA to bolster portfolio companies’ computational power - Medical Device Network

Sofinnova taps NVIDIA to bolster portfolio companies’ computational power Medical Device Network

Sofinnova closes €165M European biotech acceleration fund - Fierce Biotech

Sofinnova closes €165M European biotech acceleration fund Fierce Biotech

Sofinnova’s latest biotech fund sprouts three new startups - BioPharma Dive

Sofinnova’s latest biotech fund sprouts three new startups BioPharma Dive

Signadori Bio springs forth from Sofinnova and Gustave Roussy - The Pharma Letter

Signadori Bio springs forth from Sofinnova and Gustave Roussy The Pharma Letter

€165 million for biotech: Sofinnova Partners concludes its Biovelocita II fund, receiving support from Amgen, Bristol Myers Squibb, and Pfizer Ventures - Tech Funding News

€165 million for biotech: Sofinnova Partners concludes its Biovelocita II fund, receiving support from Amgen, Bristol Myers Squibb, and Pfizer Ventures Tech Funding News

Sofinnova Partners Raises €1.2 Billion to Fuel the Next Wave of Life Sciences Innovation - Business Wire

Sofinnova Partners Raises €1.2 Billion to Fuel the Next Wave of Life Sciences Innovation Business Wire

VC firm Sofinnova brings in €1.2B over a year to fund up to 60 life sciences companies - Fierce Biotech

VC firm Sofinnova brings in €1.2B over a year to fund up to 60 life sciences companies Fierce Biotech

Sofinnova Partners: Our evolving ESG philosophy as an early-stage venture capital investor - PRI | Home

Sofinnova Partners: Our evolving ESG philosophy as an early-stage venture capital investor PRI | Home

Sofinnova Exceeds Biotech Fund Goal and Launches Three New Companies - Inside Precision Medicine

Sofinnova Exceeds Biotech Fund Goal and Launches Three New Companies Inside Precision Medicine

Sofinnova has €1.2B to invest in up to 60 new life sciences firms - FirstWord Pharma

Sofinnova has €1.2B to invest in up to 60 new life sciences firms FirstWord Pharma

French VC Raises the Biggest Green Biotech Fund in the World - Labiotech.eu

French VC Raises the Biggest Green Biotech Fund in the World Labiotech.eu

Sofinnova raises €1.2bn to back 'up to 60' companies - pharmaphorum

Sofinnova raises €1.2bn to back 'up to 60' companies pharmaphorum

Sofinnova Partners raises €1.2 B in funding - World Bio Market Insights

Sofinnova Partners raises €1.2 B in funding World Bio Market Insights

Sofinnova Partners and Gustave Roussy launch first biotech company through Strategic Partnership - BioSpace

Sofinnova Partners and Gustave Roussy launch first biotech company through Strategic Partnership BioSpace

Capital Growth: Sofinnova Invests in Digital Medicine - Genetic Engineering and Biotechnology News

Capital Growth: Sofinnova Invests in Digital Medicine Genetic Engineering and Biotechnology News

BrightHeart Obtains Second FDA Clearance for Expansion of Platform Capabilities - Adding Tablet Support For Fetal Heart Ultrasound Evaluations - Business Wire

BrightHeart Obtains Second FDA Clearance for Expansion of Platform Capabilities - Adding Tablet Support For Fetal Heart Ultrasound Evaluations Business Wire

BrightHeart Secures FDA Clearance for First AI Software Revolutionizing Prenatal Fetal Heart Ultrasound Evaluations - Business Wire

BrightHeart Secures FDA Clearance for First AI Software Revolutionizing Prenatal Fetal Heart Ultrasound Evaluations Business Wire

Sofinnova Partners Raises $200M Digital Medicine Fund - Business Wire

Sofinnova Partners Raises $200M Digital Medicine Fund Business Wire

Sofinnova and Medicxi talk M&A, patent cliffs, and China - BioXconomy

Sofinnova and Medicxi talk M&A, patent cliffs, and China BioXconomy

Sofinnova Partners, NVIDIA Team Up for Life Science Innovation - Medical Product Outsourcing

Sofinnova Partners, NVIDIA Team Up for Life Science Innovation Medical Product Outsourcing

Sofinnova Investments Announces the Addition of Dr. Maha Radhakrishnan as Executive Partner - Business Wire

Sofinnova Investments Announces the Addition of Dr. Maha Radhakrishnan as Executive Partner Business Wire

Europe’s largest: Sofinnova Partners bags $180m biotech acceleration fund - BioXconomy

Europe’s largest: Sofinnova Partners bags $180m biotech acceleration fund BioXconomy

Sofinnova: Here's the 14-Slide Pitch Deck the VC Used to Raise $170m - businessinsider.com

Sofinnova: Here's the 14-Slide Pitch Deck the VC Used to Raise $170m businessinsider.com

Biotech Investor Sofinnova Investments Adds Executive Partner - The Wall Street Journal

Biotech Investor Sofinnova Investments Adds Executive Partner The Wall Street Journal

Investing For Life: Q&A With Sofinnova Chairman Antoine Papiernik - Global Finance Magazine

Investing For Life: Q&A With Sofinnova Chairman Antoine Papiernik Global Finance Magazine

Biogen CMO Maha Radhakrishnan joins Sofinnova—Chutes & Ladders - Fierce Biotech

Biogen CMO Maha Radhakrishnan joins Sofinnova—Chutes & Ladders Fierce Biotech

Stanford Biodesign co-founder joins Sofinnova Partners - MassDevice

Stanford Biodesign co-founder joins Sofinnova Partners MassDevice

Sofinnova Partners and Apollo Form Strategic Partnership in Life Sciences - Business Wire

Sofinnova Partners and Apollo Form Strategic Partnership in Life Sciences Business Wire

VC firm Sofinnova banks $1B from Apollo to invest in early-stage biotech solutions - Fierce Biotech

VC firm Sofinnova banks $1B from Apollo to invest in early-stage biotech solutions Fierce Biotech

Sofinnova Partners Appoints Mats Eklund as Partner and Chief Operating Officer - Business Wire

Sofinnova Partners Appoints Mats Eklund as Partner and Chief Operating Officer Business Wire

Endoron Medical raises $10 Million in Series A funding led by Sofinnova Partners to accelerate the validation of its AAA EndoStapling solution Aortoseal - Business Wire

Endoron Medical raises $10 Million in Series A funding led by Sofinnova Partners to accelerate the validation of its AAA EndoStapling solution Aortoseal Business Wire

Sofinnova invests in Abivax to delay cash crunch - Fierce Biotech

Sofinnova invests in Abivax to delay cash crunch Fierce Biotech

Apollo to Buy Stake in European Life Sciences VC Firm Sofinnova - Bloomberg.com

Apollo to Buy Stake in European Life Sciences VC Firm Sofinnova Bloomberg.com

Sofinnova Investments Appoints Dr. Jakob Dupont as Executive Partner - Business Wire

Sofinnova Investments Appoints Dr. Jakob Dupont as Executive Partner Business Wire

Techwork 2024: Stéphanie Huiban, Sofinnova Partners - The Drawdown

Techwork 2024: Stéphanie Huiban, Sofinnova Partners The Drawdown

Sofinnova raises Europe’s largest early-stage healthcare fund with €472m - Sifted

Sofinnova raises Europe’s largest early-stage healthcare fund with €472m Sifted

France: Sofinnova’s Karl Naegler talks to IIH about his appointment, the firm's early-stage investment strategy and life sciences - Investors in Healthcare

France: Sofinnova’s Karl Naegler talks to IIH about his appointment, the firm's early-stage investment strategy and life sciences Investors in Healthcare

Corvidia Therapeutics Raises $26M in a Series A Financing, Led by Sofinnova Partners and Apple Tree Partners - PR Newswire

Corvidia Therapeutics Raises $26M in a Series A Financing, Led by Sofinnova Partners and Apple Tree Partners PR Newswire

HEPTA Medical Secures €5.7 Million Series A, Led by BPI France to Advance Minimally Invasive Lung Cancer Treatment - Business Wire

HEPTA Medical Secures €5.7 Million Series A, Led by BPI France to Advance Minimally Invasive Lung Cancer Treatment Business Wire

Has Gender Diversity in Biotech changed? "No", says Managing partner of Sofinnova #BIOEurope - Labiotech.eu

Has Gender Diversity in Biotech changed? "No", says Managing partner of Sofinnova #BIOEurope Labiotech.eu

Sofinnova Partners Raises €150M for Sofinnova Industrial Biotech II - Global AgInvesting

Sofinnova Partners Raises €150M for Sofinnova Industrial Biotech II Global AgInvesting

Sofinnova Partners launches $340m healthcare crossover fund - MassDevice

Sofinnova Partners launches $340m healthcare crossover fund MassDevice

Early-Stage Medtech HighLife Nabs $14M for Transcatheter Mitral Valve Replacement - BioSpace

Early-Stage Medtech HighLife Nabs $14M for Transcatheter Mitral Valve Replacement BioSpace

Sofinnova Investments Announces the Addition of Industry Veteran Maha Katabi, PhD. as a Partner - PR Newswire Canada

Sofinnova Investments Announces the Addition of Industry Veteran Maha Katabi, PhD. as a Partner PR Newswire Canada

Natera raises $55.5 million in funding led by Sofinnova Ventures - News-Medical

Natera raises $55.5 million in funding led by Sofinnova Ventures News-Medical

Sofinnova secures €106 million biotech fund - Bioökonomie.de

Sofinnova secures €106 million biotech fund Bioökonomie.de

Sphere Fluidics secures £30 million Series B investment led by Sofinnova Partners and Redmile Group - UK Tech Investment News

Sphere Fluidics secures £30 million Series B investment led by Sofinnova Partners and Redmile Group UK Tech Investment News

Sofinnova rounds off the year with a fourth exit - Financial News London

Sofinnova rounds off the year with a fourth exit Financial News London

Pyrowave closes Series B led by Michelin and Sofinnova Partners - PR Newswire Canada

Pyrowave closes Series B led by Michelin and Sofinnova Partners PR Newswire Canada

Sofinnova Partners lève 200 M$ pour son fonds dédié à la Médecine Digitale - Business Wire

Sofinnova Partners lève 200 M$ pour son fonds dédié à la Médecine Digitale Business Wire

Top Sofinnova Partners Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant